In contrast, mice lacking Sall4 in the AY-CCA exhibited a robust reduction in gross tumor burden, evidenced by a significantly lower LW/BW ratio and diminished macroscopic tumor growth compared with Sall4 WTGFP (Fig. 1C and D). This evidence concerns the gene SALL4 and neoplasm.